Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
Recent studies identify FOXF2 and TIE2 as key genetic regulators in cerebral small vessel disease, with AKB-9778 showing promise in clinical trials for enhancing vascular health and cognitive function...
New review shows nearly half of AI imaging research targets stroke lesion segmentation, but standardization and real-world validation lag behind breakthroughs like NIH’s StrokeImageNet and FDA&#...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
Recent studies suggest time-restricted eating may delay Huntington’s disease symptoms by enhancing mitochondrial function and autophagy, with human trials currently underway. Emerging research indic...
A new clinical trial explores time-restricted eating for Huntington’s disease, building on recent research showing benefits for mitochondrial function and autophagy. A groundbreaking clinical trial ...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and autophagy in early-stage Huntington’s disease patients. Groundbreaking research i...
Emerging research suggests time-restricted feeding may improve symptoms and slow neurodegeneration in Huntington’s disease through circadian rhythm synchronization and enhanced autophagy. New cl...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Johns Hopkins Hospital’s pilot study reveals ADAM sensors with AI biofeedback improve swallow frequency by 45%, reducing aspiration pneumonia risk by 32%, now under FDA fast-track review. Breakt...
